TRCT
ELV icon

Tower Research Capital (TRC)’s Elevance Health ELV Stock Holding History

Tower Research Capital (TRC)’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$705K Sell
2,409
-2,818
-54% -$926K 0.02% 707
2025
Q4 		$1.83M Buy
5,227
+3,420
+189% +$1.16M 0.04% 355
2025
Q3 		$584K Sell
1,807
-4,471
-71% -$1.39M 0.02% 764
2025
Q2 		$2.44M Sell
6,278
-4,609
-42% -$1.85M 0.07% 266
2025
Q1 		$4.74M Sell
10,887
-1,888
-15% -$758K 0.14% 112
2024
Q4 		$4.71M Buy
12,775
+5,320
+71% +$2.23M 0.09% 172
2024
Q3 		$3.88M Sell
7,455
-1,813
-20% -$969K 0.1% 127
2024
Q2 		$5.02M Buy
9,268
+4,721
+104% +$2.5M 0.08% 194
2024
Q1 		$2.36M Sell
4,547
-26,764
-85% -$13.3M 0.06% 241
2023
Q4 		$14.8M Buy
31,311
+16,737
+115% +$7.74M 0.18% 95
2023
Q3 		$6.35M Buy
14,574
+9,266
+175% +$4.2M 0.2% 83
2023
Q2 		$2.36M Buy
5,308
+882
+20% +$407K 0.08% 200
2023
Q1 		$2.04M Buy
4,426
+325
+8% +$155K 0.06% 199
2022
Q4 		$2.1M Sell
4,101
-17,194
-81% -$8.73M 0.09% 155
2022
Q3 		$9.67M Buy
21,295
+11,816
+125% +$5.65M 0.16% 115
2022
Q2 		$4.57M Sell
9,479
-32,559
-77% -$16.1M 0.1% 163
2022
Q1 		$20.6M Buy
42,038
+26,448
+170% +$12.1M 0.2% 94
2021
Q4 		$7.23M Buy
15,590
+10,675
+217% +$4.49M 0.13% 132
2021
Q3 		$1.83M Sell
4,915
-461
-9% -$175K 0.05% 290
2021
Q2 		$2.05M Sell
5,376
-16,431
-75% -$6.28M 0.05% 295
2021
Q1 		$7.83M Buy
21,807
+16,249
+292% +$5.23M 0.13% 134
2020
Q4 		$1.78M Buy
5,558
+891
+19% +$273K 0.05% 251
2020
Q3 		$1.25M Buy
4,667
+711
+18% +$191K 0.01% 765
2020
Q2 		$1.04M Sell
3,956
-1,970
-33% -$526K 0.04% 503
2020
Q1 		$1.34M Buy
5,926
+5,586
+1,643% +$1.52M 0.08% 160
2019
Q4 		$103K Sell
340
-4,599
-93% -$1.27M 0.01% 919
2019
Q3 		$1.19M Buy
4,939
+4,866
+6,666% +$1.33M 0.08% 233
2019
Q2 		$20K Sell
73
-3,832
-98% -$1.05M ﹤0.01% 2174
2019
Q1 		$1.12M Sell
3,905
-4,981
-56% -$1.44M 0.07% 245
2018
Q4 		$2.33M Buy
8,886
+6,479
+269% +$1.78M 0.17% 127
2018
Q3 		$659K Sell
2,407
-9,188
-79% -$2.39M 0.05% 368
2018
Q2 		$2.76M Buy
11,595
+11,179
+2,687% +$2.59M 0.15% 120
2018
Q1 		$91K Sell
416
-5,740
-93% -$1.35M 0.01% 1315
2017
Q4 		$1.39M Buy
6,156
+5,818
+1,721% +$1.24M 0.18% 126
2017
Q3 		$64K Buy
+338
New +$64.3K 0.01% 1756
2017
Q2 		– Sell
-3,523
Closed -$583K – 2886
2017
Q1 		$583K Sell
3,523
-1,462
-29% -$233K 0.06% 121
2016
Q4 		$717K Buy
+4,985
New +$667K 0.08% 267
2016
Q3 		– Sell
-1,956
Closed -$257K – 3814
2016
Q2 		$257K Buy
+1,956
New +$268K 0.02% 516
2016
Q1 		– Sell
-100
Closed -$14K – 4305
2015
Q4 		$14K Sell
100
-1,200
-92% -$165K ﹤0.01% 1680
2015
Q3 		$182K Buy
+1,300
New +$195K 0.02% 310
2015
Q2 		– Sell
-700
Closed -$108K – 4520
2015
Q1 		$108K Sell
700
-2,063
-75% -$294K 0.01% 816
2014
Q4 		$347K Sell
2,763
-10,288
-79% -$1.27M 0.03% 179
2014
Q3 		$1.56M Buy
+13,051
New +$1.5M 0.18% 113
2014
Q2 		– Sell
-19,830
Closed -$1.97M – 4169
2014
Q1 		$1.97M Buy
19,830
+17,868
+911% +$1.62M 0.25% 74
2013
Q4 		$181K Sell
1,962
-3,651
-65% -$324K 0.03% 566
2013
Q3 		$470K Buy
5,613
+5,560
+10,491% +$477K 0.05% 344
2013
Q2 		$4K Buy
+53
New +$3.97K ﹤0.01% 3068

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Tower Research Capital (TRC)'s ELV Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Elevance Health (ELV) stake by 54% in Q1 2026, selling an estimated $926K and leaving 2,409 shares worth $705K. The position accounts for 0.02% of the portfolio, ranked #707.

Tower Research Capital (TRC) first reported a position in ELV in Q2 2013 and has held it in 47 quarters since. The position peaked at $20.6M in Q1 2022. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Tower Research Capital (TRC) held 2,409 shares of Elevance Health worth $705K as of Q1 2026.
  • Tower Research Capital (TRC) sold 2,818 Elevance Health shares in Q1 2026, an estimated $926K.
  • Elevance Health made up 0.02% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #707 holding.
  • Tower Research Capital (TRC) first reported a position in Elevance Health in Q2 2013 and has held it in 47 quarters since.
  • Tower Research Capital (TRC)'s Elevance Health position peaked at $20.6M in Q1 2022.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.